<DOC>
	<DOCNO>NCT03078933</DOCNO>
	<brief_summary>The clinical trial ass delivery Nitric Oxide topically diabetic foot ulcer wound surround wound area relate wound heal . The objective study ass Nitric Oxide Therapy treatment time ( number minute deliver treatment ) frequency ( number day per week treat ) determine optimal treatment time frequency develop rationale safety efficacy final APT001 clinical study .</brief_summary>
	<brief_title>A Feasibility Study Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description>APT001 medical device generates nitric oxide ( NO ) ambient room air within define plasma stream . This study randomize , prospective , multi-center feasibility study assess effect Nitric Oxide treatment time ( minute ) frequency ( days/week ) wound heal adult diabetic foot ulcer ( DFUs ) provide information use develop final safety effectiveness hypotheses pivotal trial APT001 device .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Diabetes Type 1 Type 2 Wound size great equal 1 cm2 less equal 16 cm 2 HbA1c less equal 12 % Single full thickness DFU plantar aspect toe foot Ankle Brachial Index great equal 0.7 Infection ulcer Active Charcot 's disease wound involve deep tissue include bone tendon Negative pressure therapy affect foot Hyperbaric Oxygen Therapy</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>DFU</keyword>
</DOC>